When we compare life sciences and healthcare to other industries, the strategy in the former is much more fragmented. The pricing practices are also relatively unbalanced while the product cycle is quite long as well.
Dynavax Technologies Corporation, a biopharmecuitical company that focuses on commercializing novel vaccines, today announced Andrew A. F. Hack, M.D., Ph.D., a Managing...